Multifactorial analysis of the survival of patients with distant metastasis arising from primary extremity sarcoma

Kevin Billingsley, Jonathan J. Lewis, Denis H Y Leung, Ephraim S. Casper, James M. Woodruff, Murray F. Brennan

Research output: Contribution to journalArticle

143 Citations (Scopus)

Abstract

BACKGROUND. Despite optimal multimodality limb-sparing therapy for extremity soft tissue sarcoma (STS), a significant number of patients develop distant metastasis. The objective of this study was to analyze patterns of metastatic disease and define prognostic factors for survival in a large group of patients followed prospectively at a single institution. METHODS. Between July 1, 1982, and June 30, 1996, all adult patients admitted to the Memorial Sloan-Kettering Cancer Center with primary extremity sarcoma were treated and prospectively followed. Patients who developed distant metastases constituted the study group. Prognostic factors were analyzed for postmetastasis survival. These included both factors related to the primary tumor and factors related to the pattern of metastasis. Postmetastasis survival was modeled using the Kaplan-Meier method. Statistical significance was evaluated using the log rank test for univariate analysis and the Cox proportional hazards model for multivariate analysis. RESULTS. During the study period, the authors admitted and treated 994 patients with primary extremity STS. The median follow-up was 33 months. Distant metastasis developed in 230 patients (23%). Median survival after distant metastasis was 11.6 months. The lungs were the first metastatic site in 169 patients (73%). Other first sites of metastasis included the skin and soft tissues of the head and neck, trunk, and extremities. There was no statistically significant difference in survival between patients with pulmonary and those with nonpulmonary metastatic disease. In multivariate analysis, resection of metastatic disease, the length of the disease free interval, the presence of a preceding local recurrence, and patient age > 50 years all were significant predictors of postmetastasis survival. Other factors that defined the primary tumor, including histologic grade, depth, and microscopic margins, were not associated with postmetastasis survival. CONCLUSIONS. Despite optimal multimodality therapy, 23% of the patients in this series with primary extremity sarcoma developed distant metastasis. Median survival after metastasis was approximately 1 year. After metastasis, the independent favorable factors that are associated with patient survival include resection of the metastases, a long disease free interval, the absence of preceding local recurrence, and patient age <50 years. Although a definitive conclusion regarding the benefit of resection can be made only with a randomized clinical trial, these data suggest that resection of metastatic STS may contribute to patient survival, which in some cases may be long term.

Original languageEnglish (US)
Pages (from-to)389-395
Number of pages7
JournalCancer
Volume85
Issue number2
DOIs
StatePublished - 1999
Externally publishedYes

Fingerprint

Survival Analysis
Sarcoma
Extremities
Neoplasm Metastasis
Survival
Multivariate Analysis
Recurrence
Neoplasms
Lung
Proportional Hazards Models
Neck
Randomized Controlled Trials
Head

Keywords

  • Cox proportional hazards model
  • Disease free interval
  • Metastasis
  • Prognostic factors
  • Resection
  • Soft tissue sarcoma

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Multifactorial analysis of the survival of patients with distant metastasis arising from primary extremity sarcoma. / Billingsley, Kevin; Lewis, Jonathan J.; Leung, Denis H Y; Casper, Ephraim S.; Woodruff, James M.; Brennan, Murray F.

In: Cancer, Vol. 85, No. 2, 1999, p. 389-395.

Research output: Contribution to journalArticle

Billingsley, Kevin ; Lewis, Jonathan J. ; Leung, Denis H Y ; Casper, Ephraim S. ; Woodruff, James M. ; Brennan, Murray F. / Multifactorial analysis of the survival of patients with distant metastasis arising from primary extremity sarcoma. In: Cancer. 1999 ; Vol. 85, No. 2. pp. 389-395.
@article{8d2c616cd71741c89272752359015484,
title = "Multifactorial analysis of the survival of patients with distant metastasis arising from primary extremity sarcoma",
abstract = "BACKGROUND. Despite optimal multimodality limb-sparing therapy for extremity soft tissue sarcoma (STS), a significant number of patients develop distant metastasis. The objective of this study was to analyze patterns of metastatic disease and define prognostic factors for survival in a large group of patients followed prospectively at a single institution. METHODS. Between July 1, 1982, and June 30, 1996, all adult patients admitted to the Memorial Sloan-Kettering Cancer Center with primary extremity sarcoma were treated and prospectively followed. Patients who developed distant metastases constituted the study group. Prognostic factors were analyzed for postmetastasis survival. These included both factors related to the primary tumor and factors related to the pattern of metastasis. Postmetastasis survival was modeled using the Kaplan-Meier method. Statistical significance was evaluated using the log rank test for univariate analysis and the Cox proportional hazards model for multivariate analysis. RESULTS. During the study period, the authors admitted and treated 994 patients with primary extremity STS. The median follow-up was 33 months. Distant metastasis developed in 230 patients (23{\%}). Median survival after distant metastasis was 11.6 months. The lungs were the first metastatic site in 169 patients (73{\%}). Other first sites of metastasis included the skin and soft tissues of the head and neck, trunk, and extremities. There was no statistically significant difference in survival between patients with pulmonary and those with nonpulmonary metastatic disease. In multivariate analysis, resection of metastatic disease, the length of the disease free interval, the presence of a preceding local recurrence, and patient age > 50 years all were significant predictors of postmetastasis survival. Other factors that defined the primary tumor, including histologic grade, depth, and microscopic margins, were not associated with postmetastasis survival. CONCLUSIONS. Despite optimal multimodality therapy, 23{\%} of the patients in this series with primary extremity sarcoma developed distant metastasis. Median survival after metastasis was approximately 1 year. After metastasis, the independent favorable factors that are associated with patient survival include resection of the metastases, a long disease free interval, the absence of preceding local recurrence, and patient age <50 years. Although a definitive conclusion regarding the benefit of resection can be made only with a randomized clinical trial, these data suggest that resection of metastatic STS may contribute to patient survival, which in some cases may be long term.",
keywords = "Cox proportional hazards model, Disease free interval, Metastasis, Prognostic factors, Resection, Soft tissue sarcoma",
author = "Kevin Billingsley and Lewis, {Jonathan J.} and Leung, {Denis H Y} and Casper, {Ephraim S.} and Woodruff, {James M.} and Brennan, {Murray F.}",
year = "1999",
doi = "10.1002/(SICI)1097-0142(19990115)85:2<389::AID-CNCR17>3.0.CO;2-J",
language = "English (US)",
volume = "85",
pages = "389--395",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "2",

}

TY - JOUR

T1 - Multifactorial analysis of the survival of patients with distant metastasis arising from primary extremity sarcoma

AU - Billingsley, Kevin

AU - Lewis, Jonathan J.

AU - Leung, Denis H Y

AU - Casper, Ephraim S.

AU - Woodruff, James M.

AU - Brennan, Murray F.

PY - 1999

Y1 - 1999

N2 - BACKGROUND. Despite optimal multimodality limb-sparing therapy for extremity soft tissue sarcoma (STS), a significant number of patients develop distant metastasis. The objective of this study was to analyze patterns of metastatic disease and define prognostic factors for survival in a large group of patients followed prospectively at a single institution. METHODS. Between July 1, 1982, and June 30, 1996, all adult patients admitted to the Memorial Sloan-Kettering Cancer Center with primary extremity sarcoma were treated and prospectively followed. Patients who developed distant metastases constituted the study group. Prognostic factors were analyzed for postmetastasis survival. These included both factors related to the primary tumor and factors related to the pattern of metastasis. Postmetastasis survival was modeled using the Kaplan-Meier method. Statistical significance was evaluated using the log rank test for univariate analysis and the Cox proportional hazards model for multivariate analysis. RESULTS. During the study period, the authors admitted and treated 994 patients with primary extremity STS. The median follow-up was 33 months. Distant metastasis developed in 230 patients (23%). Median survival after distant metastasis was 11.6 months. The lungs were the first metastatic site in 169 patients (73%). Other first sites of metastasis included the skin and soft tissues of the head and neck, trunk, and extremities. There was no statistically significant difference in survival between patients with pulmonary and those with nonpulmonary metastatic disease. In multivariate analysis, resection of metastatic disease, the length of the disease free interval, the presence of a preceding local recurrence, and patient age > 50 years all were significant predictors of postmetastasis survival. Other factors that defined the primary tumor, including histologic grade, depth, and microscopic margins, were not associated with postmetastasis survival. CONCLUSIONS. Despite optimal multimodality therapy, 23% of the patients in this series with primary extremity sarcoma developed distant metastasis. Median survival after metastasis was approximately 1 year. After metastasis, the independent favorable factors that are associated with patient survival include resection of the metastases, a long disease free interval, the absence of preceding local recurrence, and patient age <50 years. Although a definitive conclusion regarding the benefit of resection can be made only with a randomized clinical trial, these data suggest that resection of metastatic STS may contribute to patient survival, which in some cases may be long term.

AB - BACKGROUND. Despite optimal multimodality limb-sparing therapy for extremity soft tissue sarcoma (STS), a significant number of patients develop distant metastasis. The objective of this study was to analyze patterns of metastatic disease and define prognostic factors for survival in a large group of patients followed prospectively at a single institution. METHODS. Between July 1, 1982, and June 30, 1996, all adult patients admitted to the Memorial Sloan-Kettering Cancer Center with primary extremity sarcoma were treated and prospectively followed. Patients who developed distant metastases constituted the study group. Prognostic factors were analyzed for postmetastasis survival. These included both factors related to the primary tumor and factors related to the pattern of metastasis. Postmetastasis survival was modeled using the Kaplan-Meier method. Statistical significance was evaluated using the log rank test for univariate analysis and the Cox proportional hazards model for multivariate analysis. RESULTS. During the study period, the authors admitted and treated 994 patients with primary extremity STS. The median follow-up was 33 months. Distant metastasis developed in 230 patients (23%). Median survival after distant metastasis was 11.6 months. The lungs were the first metastatic site in 169 patients (73%). Other first sites of metastasis included the skin and soft tissues of the head and neck, trunk, and extremities. There was no statistically significant difference in survival between patients with pulmonary and those with nonpulmonary metastatic disease. In multivariate analysis, resection of metastatic disease, the length of the disease free interval, the presence of a preceding local recurrence, and patient age > 50 years all were significant predictors of postmetastasis survival. Other factors that defined the primary tumor, including histologic grade, depth, and microscopic margins, were not associated with postmetastasis survival. CONCLUSIONS. Despite optimal multimodality therapy, 23% of the patients in this series with primary extremity sarcoma developed distant metastasis. Median survival after metastasis was approximately 1 year. After metastasis, the independent favorable factors that are associated with patient survival include resection of the metastases, a long disease free interval, the absence of preceding local recurrence, and patient age <50 years. Although a definitive conclusion regarding the benefit of resection can be made only with a randomized clinical trial, these data suggest that resection of metastatic STS may contribute to patient survival, which in some cases may be long term.

KW - Cox proportional hazards model

KW - Disease free interval

KW - Metastasis

KW - Prognostic factors

KW - Resection

KW - Soft tissue sarcoma

UR - http://www.scopus.com/inward/record.url?scp=0032890566&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032890566&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1097-0142(19990115)85:2<389::AID-CNCR17>3.0.CO;2-J

DO - 10.1002/(SICI)1097-0142(19990115)85:2<389::AID-CNCR17>3.0.CO;2-J

M3 - Article

VL - 85

SP - 389

EP - 395

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 2

ER -